QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 11,420
-20 (-0.17%)
At close: May 14, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 131.13 billion as of May 15, 2026.
Market Cap
131.13B
Enterprise Value
111.09B
Revenue
10.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,420.00
Market Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 131.13B, a decrease of -34.42%. That is a compound annual growth rate of -63.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 131.13B | -25.84% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ensol Biosciences | 176.10B |
| ISU Abxis | 175.51B |
| CORESTEMCHEMON | 166.13B |
| Prestige Biologics | 163.28B |
| Cell Biotech | 117.78B |
| BIO-FD&C | 113.48B |
| NovMetaPharma | 112.36B |
| CHA Vaccine Research Institute | 99.67B |